Acromegaly: Update on Management and Long-Term Morbidities

Area of Science:

• Endocrinology
• Internal Medicine
• Metabolic Diseases

Background:

• Acromegaly is a severe systemic disease with significant morbidity and mortality.
• Advances in treatment and understanding of comorbidities have improved patient outcomes.
• Long-term management requires continuous monitoring and adaptation of care strategies.

Purpose of the Study:

• To provide an updated overview of acromegaly management based on current recommendations.
• To analyze the evolving landscape of acromegaly comorbidities in recent patient cohorts.
• To emphasize changes in disease manifestations and causes of mortality.

Main Methods:

• Review of current literature and clinical guidelines for acromegaly management.
• Analysis of recent epidemiological data on acromegaly comorbidities and mortality trends.
• Comparative assessment of disease characteristics across different time periods.

Main Results:

• Significant improvements in acromegaly treatment and management over recent decades.
• A notable decrease in the severity of cardiovascular disease in contemporary acromegaly patients.
• Increased recognition of bone disease, particularly vertebral fractures, and a shift in the primary cause of death from cardiovascular disease to cancer.

Conclusions:

• Current acromegaly management strategies have led to improved patient outcomes.
• Long-term monitoring must address the changing spectrum of comorbidities, including bone health and cancer risk.
• Understanding these evolving trends is crucial for optimizing patient care and reducing mortality.